Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

医学 心脏毒性 阿霉素 粘膜炎 蒽环类 转移性乳腺癌 内科学 呕吐 胃肠病学 中性粒细胞减少症 恶心 癌症 化疗 乳腺癌
作者
Mary E.R. O'Brien,Nely Wigler,Moshe Inbar,Renzo Rosso,Eva‐Maria Grischke,Armando Santoro,Raphael Catane,Dirk Kieback,Piotr Tomczak,Stephen P. Ackland,F.J. Orlandi,L. Mellars,Leila Alland,Craig L. Tendler
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:15 (3): 440-449 被引量:1909
标识
DOI:10.1093/annonc/mdh097
摘要

This study was designed to demonstrate that efficacy [progression-free survival (PFS)] of CAELYX [pegylated liposomal doxorubicin HCl (PLD)] is non-inferior to doxorubicin with significantly less cardiotoxicity in first-line treatment of women with metastatic breast cancer (MBC).Women (n=509) with MBC and normal cardiac function were randomized to receive either PLD 50 mg/m2 (every 4 weeks) or doxorubicin 60 mg/m2 (every 3 weeks). Cardiac event rates were based on reductions in left ventricular ejection fraction as a function of cumulative anthracycline dose.PLD and doxorubicin were comparable with respect to PFS [6.9 versus 7.8 months, respectively; hazard ratio (HR)=1.00; 95% confidence interval (CI) 0.82-1.22]. Subgroup results were consistent. Overall risk of cardiotoxicity was significantly higher with doxorubicin than PLD (HR=3.16; 95%CI 1.58-6.31; P<0.001). Overall survival was similar (21 and 22 months for PLD and doxorubicin, respectively; HR=0.94; 95%CI 0.74-1.19). Alopecia (overall, 66% versus 20%; pronounced, 54% versus 7%), nausea (53% versus 37%), vomiting (31% versus 19%) and neutropenia (10% versus 4%) were more often associated with doxorubicin than PLD. Palmar-plantar erythrodysesthesia (48% versus 2%), stomatitis (22% versus 15%) and mucositis (23% versus 13%) were more often associated with PLD than doxorubicin.In first-line therapy for MBC, PLD provides comparable efficacy to doxorubicin, with significantly reduced cardiotoxicity, myelosuppression, vomiting and alopecia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
科研通AI6.2的应助被开心德地采纳,获得10
3秒前
3秒前
万能图书馆的应助被李富杰采纳,获得10
3秒前
上官若男的应助被还读书呢采纳,获得10
3秒前
传奇3的应助被DW采纳,获得10
3秒前
3秒前
cdercder的应助被科研通管家采纳,获得10
3秒前
852的应助被噜噜噜采纳,获得10
3秒前
Jasper的应助被科研通管家采纳,获得10
4秒前
wang发布了新的文献求助10
4秒前
酷波er的应助被科研通管家采纳,获得10
4秒前
syvshc的应助被科研通管家采纳,获得10
4秒前
天天向上的应助被科研通管家采纳,获得10
4秒前
共享精神的应助被科研通管家采纳,获得10
4秒前
0.5地板砖完成签到,获得积分20
4秒前
zyy发布了新的文献求助10
4秒前
CodeCraft的应助被科研通管家采纳,获得10
4秒前
积极小懒虫完成签到,获得积分10
4秒前
4秒前
研友_wZrxbL发布了新的文献求助10
4秒前
领导范儿的应助被科研通管家采纳,获得10
4秒前
4秒前
FashionBoy的应助被科研通管家采纳,获得30
5秒前
贾贡献的应助被yangyangyang采纳,获得10
5秒前
cdercder的应助被科研通管家采纳,获得10
5秒前
5秒前
5秒前
Siri发布了新的文献求助10
5秒前
Akim的应助被科研通管家采纳,获得30
5秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
5秒前
1101592875的应助被科研通管家采纳,获得10
5秒前
香蕉觅云的应助被科研通管家采纳,获得10
5秒前
烟花的应助被科研通管家采纳,获得10
6秒前
大模型的应助被科研通管家采纳,获得10
6秒前
6秒前
妖九笙发布了新的文献求助10
6秒前
打打的应助被科研通管家采纳,获得10
6秒前
搜集达人的应助被科研通管家采纳,获得10
6秒前
深情安青的应助被科研通管家采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188210
求助须知:如何正确求助?哪些是违规求助? 9576001
关于积分的说明 21844898
捐赠科研通 7786081
什么是DOI,文献DOI怎么找? 3435220
关于科研通互助平台的介绍 2559559
邀请新用户注册赠送积分活动 2482139